About
National initiative at Morgridge Hall, University of Wisconsin. Previous iterations brought together 60+ faculty from 30+ universities. NDA submission targeted for 2026.
Focus areas
Depth orientation
Usona Institute is conducting Phase 3 clinical trials of psilocybin for major depressive disorder. This program convenes academic faculty to develop rigorous psychedelic education at the university level.
Who it’s for
University faculty, Researchers, Clinicians, Educators